Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from ImExHS Limited ( (AU:IME) ) is now available.
ImExHS Limited has announced a change in the director’s interest notice, specifically involving Douglas Lingard. On September 8, 2025, Mr. Lingard acquired 53,485 fully paid ordinary shares directly, in lieu of non-executive director fees for the quarters ending June 30 and September 30, 2025. This acquisition reflects a strategic decision to align director compensation with company performance, potentially impacting investor perceptions and stakeholder confidence in the company’s governance practices.
The most recent analyst rating on (AU:IME) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on ImExHS Limited stock, see the AU:IME Stock Forecast page.
More about ImExHS Limited
ImExHS Limited operates in the healthcare technology industry, focusing on providing innovative medical imaging solutions. The company specializes in developing and delivering advanced imaging software and services, catering to healthcare providers and institutions seeking efficient and effective diagnostic tools.
Average Trading Volume: 29,847
Technical Sentiment Signal: Sell
Current Market Cap: A$13.41M
For an in-depth examination of IME stock, go to TipRanks’ Overview page.